Works matching IS 14248247 AND DT 2022 AND VI 15 AND IP 3
Results: 124
Polyphenols as Inhibitors of Antibiotic Resistant Bacteria—Mechanisms Underlying Rutin Interference with Bacterial Virulence.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 385, doi. 10.3390/ph15030385
- By:
- Publication type:
- Article
Recommendations to Synthetize Old and New β-Lactamases Inhibitors: A Review to Encourage Further Production.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 384, doi. 10.3390/ph15030384
- By:
- Publication type:
- Article
Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 383, doi. 10.3390/ph15030383
- By:
- Publication type:
- Article
Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 382, doi. 10.3390/ph15030382
- By:
- Publication type:
- Article
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 381, doi. 10.3390/ph15030381
- By:
- Publication type:
- Article
Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 380, doi. 10.3390/ph15030380
- By:
- Publication type:
- Article
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 379, doi. 10.3390/ph15030379
- By:
- Publication type:
- Article
Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 378, doi. 10.3390/ph15030378
- By:
- Publication type:
- Article
Inhibition of Respiratory RNA Viruses by a Composition of Ionophoric Polyphenols with Metal Ions.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 377, doi. 10.3390/ph15030377
- By:
- Publication type:
- Article
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 376, doi. 10.3390/ph15030376
- By:
- Publication type:
- Article
Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 375, doi. 10.3390/ph15030375
- By:
- Publication type:
- Article
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 374, doi. 10.3390/ph15030374
- By:
- Publication type:
- Article
Polymorphic and Higher-Order G-Quadruplexes as Possible Transcription Regulators: Novel Perspectives for Future Anticancer Therapeutic Applications.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 373, doi. 10.3390/ph15030373
- By:
- Publication type:
- Article
Up-to-Date Overview of the Use of Natural Ingredients in Sunscreens.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 372, doi. 10.3390/ph15030372
- By:
- Publication type:
- Article
Current and Future Prospective of Injectable Hydrogels—Design Challenges and Limitations.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 371, doi. 10.3390/ph15030371
- By:
- Publication type:
- Article
Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 370, doi. 10.3390/ph15030370
- By:
- Publication type:
- Article
Lycorine Ameliorates Thioacetamide-Induced Hepatic Fibrosis in Rats: Emphasis on Antioxidant, Anti-Inflammatory, and STAT3 Inhibition Effects.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 369, doi. 10.3390/ph15030369
- By:
- Publication type:
- Article
Enantioselectivity of Pentedrone and Methylone on Metabolic Profiling in 2D and 3D Human Hepatocyte-like Cells.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 368, doi. 10.3390/ph15030368
- By:
- Publication type:
- Article
E-Cigarette Aerosol Deposition and Disposition of [ 11 C]Nicotine Using Positron Emission Tomography: A Comparison of Nicotine Uptake in Lungs and Brain Using Two Different Nicotine Formulations.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 367, doi. 10.3390/ph15030367
- By:
- Publication type:
- Article
Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 366, doi. 10.3390/ph15030366
- By:
- Publication type:
- Article
Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 365, doi. 10.3390/ph15030365
- By:
- Publication type:
- Article
Quercetin and Quercitrin from Agrimonia pilosa Ledeb Inhibit the Migration and Invasion of Colon Cancer Cells through the JNK Signaling Pathway.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 364, doi. 10.3390/ph15030364
- By:
- Publication type:
- Article
Mitophagy Mediates the Beige to White Transition of Human Primary Subcutaneous Adipocytes Ex Vivo.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 363, doi. 10.3390/ph15030363
- By:
- Publication type:
- Article
Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 362, doi. 10.3390/ph15030362
- By:
- Publication type:
- Article
Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 361, doi. 10.3390/ph15030361
- By:
- Publication type:
- Article
Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-Trioxanes.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 360, doi. 10.3390/ph15030360
- By:
- Publication type:
- Article
Medical Cannabis in Pediatric Oncology: Friend or Foe?
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 359, doi. 10.3390/ph15030359
- By:
- Publication type:
- Article
Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 358, doi. 10.3390/ph15030358
- By:
- Publication type:
- Article
Novel In Vivo Assessment of Antimicrobial Efficacy of Ciprofloxacin Loaded Mesoporous Silica Nanoparticles against Salmonella typhimurium Infection.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 357, doi. 10.3390/ph15030357
- By:
- Publication type:
- Article
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 356, doi. 10.3390/ph15030356
- By:
- Publication type:
- Article
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 355, doi. 10.3390/ph15030355
- By:
- Publication type:
- Article
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 354, doi. 10.3390/ph15030354
- By:
- Publication type:
- Article
In Vitro and In Vivo Evaluation of a Cyclic LyP-1-Modified Nanosystem for Targeted Endostatin Delivery in a KYSE-30 Cell Xenograft Athymic Nude Mice Model.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 353, doi. 10.3390/ph15030353
- By:
- Publication type:
- Article
Review on the Synthesis and Therapeutic Potential of Pyrido[2,3- d ], [3,2- d ], [3,4- d ] and [4,3- d ]pyrimidine Derivatives.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 352, doi. 10.3390/ph15030352
- By:
- Publication type:
- Article
In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 351, doi. 10.3390/ph15030351
- By:
- Publication type:
- Article
The Anti-Inflammatory Effect of Humulus lupulus Extract In Vivo Depends on the Galenic System of the Topical Formulation.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 350, doi. 10.3390/ph15030350
- By:
- Publication type:
- Article
Correction: Sato-Akushichi et al. Choroidal Volume Evaluation after Photodynamic Therapy Using New Optical Coherence Tomography Imaging Algorithm. Pharmaceuticals 2021, 14 , 1140.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 348, doi. 10.3390/ph15030348
- By:
- Publication type:
- Article
ApoA-I Nanoparticles as Curcumin Carriers for Cerebral Endothelial Cells: Improved Cytoprotective Effects against Methylglyoxal.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 347, doi. 10.3390/ph15030347
- By:
- Publication type:
- Article
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists?
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 346, doi. 10.3390/ph15030346
- By:
- Publication type:
- Article
Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 345, doi. 10.3390/ph15030345
- By:
- Publication type:
- Article
Two Lignan Glycosides from Albizia julibrissin Durazz. Noncompetitively Inhibit Serotonin Transporter.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 344, doi. 10.3390/ph15030344
- By:
- Publication type:
- Article
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 343, doi. 10.3390/ph15030343
- By:
- Publication type:
- Article
Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 342, doi. 10.3390/ph15030342
- By:
- Publication type:
- Article
Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 341, doi. 10.3390/ph15030341
- By:
- Publication type:
- Article
Plant Terpenoids as Hit Compounds against Trypanosomiasis.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 340, doi. 10.3390/ph15030340
- By:
- Publication type:
- Article
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 339, doi. 10.3390/ph15030339
- By:
- Publication type:
- Article
Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 338, doi. 10.3390/ph15030338
- By:
- Publication type:
- Article
Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT 1A Receptor Biased Agonist.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 337, doi. 10.3390/ph15030337
- By:
- Publication type:
- Article
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 336, doi. 10.3390/ph15030336
- By:
- Publication type:
- Article